Commentary: Is neoadjuvant chemoimmunotherapy for esophageal cancer the next great frontier?

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Journal	Journal of Thoracic and Cardiovascular Surgery
DOIs	https://doi.org/10.1016/j.jtcvs.2024.01.025
State	Accepted/In press - 2024

ASJC Scopus subject areas

@article{4108d1f1b7334a108d266174bbda0b38,

title = "Commentary: Is neoadjuvant chemoimmunotherapy for esophageal cancer the next great frontier?",

author = "Lee, {Rachel M.} and Antonoff, {Mara B.}",

year = "2024",

doi = "10.1016/j.jtcvs.2024.01.025",

language = "English (US)",

journal = "Journal of Thoracic and Cardiovascular Surgery",

issn = "0022-5223",

publisher = "Mosby Inc.",

}

TY - JOUR

T1 - Commentary

T2 - Is neoadjuvant chemoimmunotherapy for esophageal cancer the next great frontier?

AU - Lee, Rachel M.

AU - Antonoff, Mara B.

PY - 2024

Y1 - 2024

UR - http://www.scopus.com/inward/record.url?scp=85185583740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85185583740&partnerID=8YFLogxK

U2 - 10.1016/j.jtcvs.2024.01.025

DO - 10.1016/j.jtcvs.2024.01.025

M3 - Editorial

C2 - 38246341

AN - SCOPUS:85185583740

SN - 0022-5223

JO - Journal of Thoracic and Cardiovascular Surgery

JF - Journal of Thoracic and Cardiovascular Surgery

ER -